Sarepta Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $71M | 740k | 96.43 |
| 2023-09-30 | $96M | 788k | 121.22 |
| 2023-06-30 | $89M | 781k | 114.52 |
| 2023-03-31 | $162M | 1.2M | 137.83 |
| 2022-12-31 | $108M | 837k | 129.58 |
| 2022-03-31 | $89M | 1.1M | 78.12 |
| 2021-12-31 | $66M | 736k | 90.05 |
| 2021-09-30 | $66M | 709k | 92.48 |
| 2021-06-30 | $56M | 721k | 77.74 |
| 2021-03-31 | $53M | 704k | 74.53 |
| 2020-12-31 | $222M | 1.3M | 170.49 |
| 2020-09-30 | $188M | 1.3M | 140.43 |
| 2020-06-30 | $251M | 1.6M | 160.34 |
| 2020-03-31 | $165M | 1.7M | 97.82 |
| 2019-12-31 | $429M | 3.3M | 129.04 |
| 2019-09-30 | $285M | 3.8M | 75.32 |
| 2019-06-30 | $593M | 3.9M | 151.95 |
| 2019-03-31 | $422M | 3.5M | 119.19 |
| 2018-12-31 | $479M | 4.4M | 109.13 |
| 2018-09-30 | $658M | 4.1M | 161.51 |
| 2018-06-30 | $594M | 4.5M | 132.18 |
| 2018-03-31 | $252M | 3.4M | 74.09 |
| 2017-12-31 | $104M | 1.9M | 55.64 |
| 2017-06-30 | $9.0M | 267k | 33.71 |
| 2017-03-31 | $11M | 361k | 29.60 |
| 2016-12-31 | $11M | 381k | 27.43 |
| 2016-09-30 | $33M | 535k | 61.41 |
| 2016-06-30 | $1.1M | 59k | 19.08 |
| 2016-03-31 | $1.0M | 53k | 19.52 |
| 2015-12-31 | $1.2M | 32k | 38.59 |
| 2015-09-30 | $1.0M | 32k | 32.11 |
| 2015-03-31 | $353k | 27k | 13.30 |
| 2014-12-31 | $205k | 14k | 14.49 |
| 2014-06-30 | $421k | 14k | 29.76 |
| 2014-03-31 | $280k | 12k | 24.04 |
| 2013-09-30 | $805k | 17k | 47.22 |
| 2013-06-30 | $33M | 874k | 38.05 |
| 2013-03-31 | $33M | 881k | 36.95 |
| 2012-12-31 | $23M | 876k | 25.80 |
| 2012-09-30 | $380k | 24k | 15.54 |